<DOC>
	<DOCNO>NCT02239094</DOCNO>
	<brief_summary>We propose conduct pilot study biological predictor lurasidone response bipolar depression .</brief_summary>
	<brief_title>Biosignatures Latuda Bipolar Depression</brief_title>
	<detailed_description>We propose enroll 20 participant bipolar disorder currently episode major depression.We shall conduct magnetic resonance imaging ( MRI ) , recording brain electrical activity ( EEG ) , psychological testing explore possible predictor lurasidone treatment response . Blood sample collect future study blood protein predictor response . After test , participant receive open-label 8-week trial lurasidone ( Latudaâ„¢ ) approve dosage level . Participants attain remission major depressive episode eligible six-month continuation phase explore predictor sustain response continuation treatment . Data analysis use statistical test explore potential biological predictor lurasidone response . This provide framework clarify patient best suit treatment begin develop model precision treatment difficult-to-treat disorder .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lurasidone Hydrochloride</mesh_term>
	<criteria>1 . Age 18 60 2 . Outpatients primary Diagnostic Statistical Manual American Psychiatric Association , Fourth Edition ( DSMIV ) diagnosis Bipolar Disorder I , II , NOS ( Not Otherwise Specified ) 3 . Current episode Major Depression 4 . At least moderate severity depression 5 . Agrees , eligible , electroencephalogram ( EEG ) / psychological testing , magnetic resonance imaging ( MRI ) , blood draws 6 . Provides inform consent 1 . Current drug alcohol abuse/dependence , except nicotine ( within 6 month dependence ; 2 abuse ) 2 . Taking follow exclusionary medication : antipsychotic , anticonvulsant , mood stabilizer , stimulant , antidepressant medication , medication significant interaction lurasidone , except washout prior test blood collection 3 . Unstable medical condition , include significant liver disease , hypothyroidism ( i.e. , condition adequately stabilize 3 month ) , condition likely require hospitalization life expectancy &lt; 6 mo . * 4 . Patients consider significant risk suicide 5 . Inadequate understanding English 6 . Currently pregnant breastfeeding ; fecund woman use adequate contraceptive method ; plan become pregnant within 12 month 7 . Contraindications MRI ( e.g . ferromagnetic body implant , history metal work , etc . ) 8 . Have epilepsy , neuromuscular disorder , tardive dyskinesia 9 . Require immediate hospitalization psychiatric disorder 10 . Require medication general medical condition contraindicate study medication** 11 . Receiving receive index episode vagus nerve stimulation , electroconvulsive therapy , transcranial magnetic stimulation , somatic treatment 12 . Allergy , medical contraindication lurasidone treatment 13 . Currently enrol another research study , participation study contraindicate participation 14 . Clinically significant screen laboratory abnormality ( * see ) 15 . Currently take effective mood stabilizer and/or antidepressant regimen 16 . Inability undergo three week medicationfree period , include history significant clinical deterioration past period medication medication dosage reduce , include mania , severe depression , etc . 17 . Any reason list herein would make participation study hazardous *Medical criterion exclusion : Untreated hypertension : &gt; 140/90 Torr repeat measurement ( If hypertension become stabilize , subject may enroll study ) Hepatitis : liver function test &gt; 2x upper limit normal Renal failure : estimate Glomerular Filtration Rate ( eGFR , correct body surface area ) repeatedly &lt; 30 mL/min Hypothyroidism : thryrotropin stimulate hormone level &gt; upper limit normal ( unless accompany euthyroid index confirmation internist endocrinologist represent hypothyroidism ) Anemia : hemoglobin &lt; 10 grams/deciliter ( borderline hemoglobin must know origin , stable , clinically significant )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Bipolar Disorder</keyword>
	<keyword>depression</keyword>
	<keyword>Bipolar depression</keyword>
</DOC>